Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.900
+0.260 (5.60%)
Apr 1, 2026, 4:00 PM EDT - Market closed
Bicycle Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$14.00
Upside
+185.71%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $44 → $36 | Buy | Maintains | $44 → $36 | +634.69% | Mar 18, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $11 → $7 | Hold | Maintains | $11 → $7 | +42.86% | Mar 18, 2026 |
| Citizens | Citizens | Buy Maintains $12 → $8 | Buy | Maintains | $12 → $8 | +63.27% | Mar 18, 2026 |
| Needham | Needham | Strong Buy Maintains $24 → $15 | Strong Buy | Maintains | $24 → $15 | +206.12% | Mar 18, 2026 |
| Truist Securities | Truist Securities | Hold Initiates $10 | Hold | Initiates | $10 | +104.08% | Nov 24, 2025 |
| Citizens | Citizens | Buy Maintains $10 → $12 | Buy | Maintains | $10 → $12 | +144.90% | Oct 31, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $27 → $11 | Buy → Hold | Downgrades | $27 → $11 | +124.49% | Oct 31, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $22 → $10 | Buy | Maintains | $22 → $10 | +104.08% | Aug 12, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $17 → $13 | Hold | Maintains | $17 → $13 | +165.31% | Aug 12, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $48 → $44 | Buy | Maintains | $48 → $44 | +797.96% | Aug 11, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $32 → $25 | Buy | Maintains | $32 → $25 | +410.20% | Jul 17, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | +246.94% | May 6, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $35 → $32 | Buy | Maintains | $35 → $32 | +553.06% | May 2, 2025 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $17 → $14 | Hold | Maintains | $17 → $14 | +185.71% | May 2, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $26 → $22 | Buy | Maintains | $26 → $22 | +348.98% | May 2, 2025 |
| Needham | Needham | Strong Buy Reiterates $29 | Strong Buy | Reiterates | $29 | +491.84% | May 2, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.